C₁₅H₂₅NO₃ (P274)
Quantities
| P2067 | mass | 267.183444 |
| P3780 | active ingredient in | ... | Q47521783 (Lopressor) | Lopressor |
| P3780 | active ingredient in | ... | Q47521829 (Toprol) | Toprol |
| P233 | canonical SMILES | String | CC(C)NCC(COC1=CC=C(C=C1)CCOC)O | ??? |
| P373 | Commons category | String | Metoprolol | ??? |
| P703 | found in taxon | ... | Q34887 (Carica papaya) | Carica papaya |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P176 | manufacturer | ... | Q206921 (Pfizer) | Pfizer |
| P2175 | medical condition treated | ... | Q12152 (myocardial infarction) | myocardial infarction |
| P2175 | medical condition treated | ... | Q189331 (heart arrhythmia) | heart arrhythmia |
| P2175 | medical condition treated | ... | Q190805 (heart disease) | heart disease |
| P2175 | medical condition treated | ... | Q56002 (ventricular tachycardia) | ventricular tachycardia |
| P2175 | medical condition treated | ... | Q180762 (angina pectoris) | angina pectoris |
| P2175 | medical condition treated | ... | Q41861 (arterial hypertension) | arterial hypertension |
| P2175 | medical condition treated | ... | Q1598909 (supraventricular tachycardia) | supraventricular tachycardia |
| P2175 | medical condition treated | ... | Q19000661 (congestive heart failure) | congestive heart failure |
| P2175 | medical condition treated | ... | Q815819 (atrial fibrillation) | atrial fibrillation |
| P2175 | medical condition treated | ... | Q848662 (ventricular fibrillation) | ventricular fibrillation |
| P129 | physically interacts with | ... | Q287958 (Adrenoceptor beta 1) | Adrenoceptor beta 1 |
| P129 | physically interacts with | ... | Q287961 (adrenoceptor beta 2) | adrenoceptor beta 2 |
| P3489 | pregnancy category | ... | Q3679261 (Australian pregnancy category C) | Australian pregnancy category C |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P636 | route of administration | ... | Q285166 (oral administration) | oral administration |
| P636 | route of administration | ... | Q640448 (intravenous infusion and defusion) | intravenous infusion and defusion |
| P769 | significant drug interaction | ... | Q216935 (lidocaine) | lidocaine |
| P769 | significant drug interaction | ... | Q412621 (methyldopa) | methyldopa |
| P769 | significant drug interaction | ... | Q415259 (terbinafine) | terbinafine |
| P769 | significant drug interaction | ... | Q418480 (tamsulosin) | tamsulosin |
| P769 | significant drug interaction | ... | Q410492 (lercanidipine) | lercanidipine |
| P769 | significant drug interaction | ... | Q411887 (rivastigmine) | rivastigmine |
| P769 | significant drug interaction | ... | Q412221 (clonidine) | clonidine |
| P769 | significant drug interaction | ... | Q408637 (dronedarone) | dronedarone |
| P769 | significant drug interaction | ... | Q410061 (amiodarone) | amiodarone |
| P769 | significant drug interaction | ... | Q410291 (verapamil) | verapamil |
| P769 | significant drug interaction | ... | Q280786 (terazosin) | terazosin |
| P769 | significant drug interaction | ... | Q419939 (doxazosin) | doxazosin |
| P769 | significant drug interaction | ... | Q419944 (moxonidine) | moxonidine |
| P769 | significant drug interaction | ... | Q422222 (digoxin) | digoxin |
| P769 | significant drug interaction | ... | Q422229 (diltiazem) | diltiazem |
| P769 | significant drug interaction | ... | Q425137 (fingolimod) | fingolimod |
| P769 | significant drug interaction | ... | Q425296 (prazosin) | prazosin |
| P769 | significant drug interaction | ... | Q2736873 (alfuzosin) | alfuzosin |
| P769 | significant drug interaction | ... | Q5186964 (crizotinib) | crizotinib |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q241549 (antiarrhythmic agent) | antiarrhythmic agent |
| P2868 | subject has role | ... | Q1752522 (Sympatholytic) | Sympatholytic |
| P2868 | subject has role | ... | Q50430373 (Adrenergic beta-1 Receptor Antagonists) | Adrenergic beta-1 Receptor Antagonists |
| P2868 | subject has role | ... | Q575890 (antihypertensive drug) | antihypertensive drug |
| P2868 | subject has role | ... | Q816759 (beta blocker) | beta blocker |
Why not click here or view trends?
log id: 1412732